149 results on '"Gapon, L. I."'
Search Results
52. Clinical efficacy of sympathetic denervation of renal arteries in patients with resistant arterial hypertension as part of annual prospective follow-up
53. PROGNOSTIC VALUE OF BLOOD PRESSURE CIRCADIAN RHYTHM DISTURBANCES IN NORMOTENSIVE SHIFT WORKERS OF THE ARCTIC POLAR REGION
54. ENDOTHELIAL DYSFUNCTION AND HEART RATE VARIABILITY IN PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY ARTERY DISEASE
55. Advantages of individual approach to chronotherapy in Yamal hypertensive shift workers
56. CHALLENGING PROBLEMS OF HYPERTENSION MANAGEMENT: THE EFFECT OF INCREASED HEART RATE AND COMORBIDITIES ON THE CHOICE OF ANTIHYPERTENSIVE THERAPY IN PRACTICE OF CARDIOLOGIST AND THERAPIST. The Conclusion of the Expert Council
57. Chronostructure of blood pressure in shift-workers in the Arctic polar region
58. Osobennosti adaptatsionnykh mekhanizmov u bol'nykh arterial'noy gipertoniey i zdorovykh lits v usloviyakh vakhty na Kraynem Severe po dannym dozirovannoy fizicheskoy nagruzki
59. Vozmozhnosti metoda khronoterapii arterial'noy gipertonii v usloviyakh vakhty v Zapolyar'e
60. Problemy priverzhennosti antigipertenzivnoy terapii v usloviyakh vakhty v Zapolyar'e
61. 24-hour blood pressure profile and heart rate variability in patients with arterial hypertension and coronary artery disease in indigenous peoples of the Far North
62. Prospective analysis of lipid profile parameters, inflammatory response and endothelial function markers before and after percutaneus coronary intervention in patients with stable angina
63. Comparative characteristic of heart rate variability and biochemical parameters in relation to night-shift work in hypertensive patients permanently living in Tyumen Priobje
64. USE OF FIXED COMBINATIONS OF RAMIPRIL AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH OR VERY HIGH CARDIOVASCULAR RISK (OPTIMIST 2 STUDY): RESULTS OF THE NONCOMPARATIVE STUDY
65. COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL
66. COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL
67. EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY)
68. Antigipertenzivnaya effektivnost' antagonistov kal'tsiya u bol'nykhs arterial'noy gipertoniey v zavisimosti ot riskaserdechno-sosudistykh oslozhneniy
69. Evaluation of the effects of atenolol and nifedipine retard on the functional status of cerebral circulation in patients with arterial hypertension in relation to risk factors
70. Efficacy of cardyl and corinpharin patients with hypertension in various types of hemodynamics
71. ENDOTHELIAL FUNCTION AND HEART RATE VARIABILITY IN PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY ARTERY DISEASE DEPENDING ON CIRCADIAN RHYTHM OF BLOOD PRESSURE
72. Cerebral blood flow and endothelial functional activity in patients with coronary heart disease and arterial hypertension during therapy with ivabradine in combination with Perindopril
73. Comparative study of hypotensive effects of foridon and corinfar (results of the single-blind placebo-controlled study),Sravnitel'noe izuchenie gipotenzivnoǐ aktivnosti foridona i korinfara (rezul'taty slepogo platsebo-kontroliruemogo issledovaniia)
74. Characteristics of the inflammatory response in patients with coronary artery disease and arterial hypertension
75. Association between biochemical markers of lipid profile and inflammatory reaction and stiffness of the vascular wall in hypertensive patients with abdominal obesity
76. Vascular wall stiffness parameters as risk factors of cerebrovascular complications in hypertensive patients with abdominal obesity
77. STRUCTURAL-FUNCTIONAL PROPERTIES OF THE VASCULAR WALL IN HYPERTENSIVE PATIENTS WITH CORONARY HEART DISEASE: EFFECTS OF FELODIPIN AND PERINDOPRIL
78. Comparative characteristics of carotid atherosclerosis in patients with hypertension concurrent with chronic coronary heart disease among the indigenous and non-indigenous population of the Yamal-Nenets Autonomic District
79. The laser therapy of hypertension patients in the initial stages | Lazerterapiia bol'nykh gipertonicheskoi bolezn'iu v nachal'nykh stadiiakh
80. Relationship between circadian rhythm of arterial pressure, vascular wall stiffness parameters and markers of vascular inflammatory reaction in postmenopausal patients
81. Development and course of arterial hypertension based on 24-hour monitoring of arterial pressure in a population of the Tyumen region,Razvitie i techenie arterial'noi gipertonii po dannym sutochnogo monitorirovaniia arterial'nogo davleniia v usloviiakh Tiumenskogo priob'ia
82. Characteristics of circadian rhythms of arterial pressure and heart rate in hypertensive subjects living in the North of the Tiumen' region | Osobennosti tsirkadiannykh ritmov arterial'nogo davleniia i chastoty serdechnykh sokrashchenii u bol'nykh arterial'noi gipertoniei, postoianno prozhivaiushchikh v usloviiakh Tiumenskogo Pripoliar'ia
83. Clinical and vascular effects of ace inhibitor enalapril in combination with thiaside-like diuretic indapamide in hypertensive outpatients. Results of the multicenter trial poema
84. Effects of angiotensin-converting enzyme (ACE) inhibitors on water-salt homeostasis in hypertensive patients living in Far North | Vliianie ingibitorov angitenzinprevrashchaiushchego fermenta na sostoianie vodno-solevogo gomeostaza u bol'nykh arterial'noi gipertoniei v usloviiakh Krainego Severa
85. Impact of the membranous physical status of neutrophils on their functional and metabolic activity in patients with hypertensive disease
86. Relationship Between the Biomarkers of Collagen Regulation and Echocardiography Parameters in Patients With Heart Failure With Preserved Ejection Fraction.
87. Characterization of blood biomarkers in prospective follow-up of patients with cardiovascular pathology in combination with type 2 diabetes mellitus after COVID-19 associated pneumonia.
88. Prospective analysis of laboratory blood parameters in patients with cardiovascular diseases who underwent COVID-19-associated pneumonia.
89. Estimation of erythrocyte parameters of general blood analysis in patients with SARS-CoV-2 -associated pneumonia.
90. Gender characteristics of lipid profile parameters and markers of vascular inflammation in patients with stable angina pectoris in groups with presence and absence of type 2 diabetes.
91. [The role of therapeutic exercises in blood pressure correction, vascular wall stiffness and disorders of bone and mineral metabolism in postmenopausal hypertensive patients].
92. [The role of vitamin D in the pathogenesis of arterial hypertension.]
93. [Nonspecific parameters of the immune inflammatory response as a link in the pathogenesis of remodeling of the vascular wall and destruction of bone tissue in women with arterial hypertension in postmenopausal women.]
94. [Prospective analysis of lipid profile parameters and markers of vascular inflammatory response with prognosis of undesirable coronary events in patients with coronary heart disease after angioplasty with stenting.]
95. [Comparative characteristics of carotid atherosclerosis in patients with hypertension concurrent with chronic coronary heart disease among the indigenous and non-indigenous population of the Yamal-Nenets Autonomic District].
96. [Analysis of 24-hour blood pressure profile, heart rate variability and carotid atherosclerosis in hypertensive patients among native and nonnative population living in Yamalo-Nenets autonomous district].
97. [Results of duplex scanning of brachiocephalic arteries and estimation of the lipid spectrum in coronary heart disease and arterial hypertension in indigenous and alien population of Yamalo-Nenetsky Autonomous District].
98. [Comparative characteristics of 24-hour blood pressure profile and heart rate variability in indigenous and non-indigenous patients with chronic coronary heart disease and hypertension from the Yamal-Nenets Autonomic District].
99. [Cerebral blood flow and endothelial functional activity in patients with coronary heart disease and arterial hypertension during therapy with ivabradine in combination with perindopril].
100. [Angiotensin converting enzyme inhibitor perindopril in the treatment of patients with arterial hypertension and renal failure].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.